Advancing Immunovirotherapy with Zika virus to treat high-grade brain tumors

作者
Sharmila Nair,Milan G. Chheda,Michael Diamond
出处
期刊:Journal of Immunology [American Association of Immunologists]
卷期号:210 (Supplement_1): 245.10-245.10
标识
DOI:10.4049/jimmunol.210.supp.245.10
摘要

Abstract High-grade brain tumors such as glioblastoma multiforme (GBM) are the most aggressive primary brain tumor and virtually all patients die within 2 years of diagnosis. Poor patient outcomes are caused by two known factors. First, presence of GBM stem cells (GSCs) which are a subpopulation of tumor cells that are resistant to radiation treatment and chemotherapy. GSCs drive tumor initiation and are the primary cause for tumor relapses. Currently, no treatment consistently kills these highly resistant cells. Second, the cold tumor microenvironment is filled with anti-inflammatory T cells and myeloid suppressor cells contributing to a weak anti-tumor immunological response. Oncolytic viral treatments are considered an attractive treatment option for high-grade solid tumors as they are engineered to replicate and destroy transformed cells as well as improve inflammatory immune responses against the tumor. However, none are specifically designed to kill GSCs. We previously tested and demonstrated that the natural tropism of Zika virus (ZIKV) can be harnessed to target and kill GSCs. In vivo we demonstrated that intratumoral ZIKV treatment was enough to improve the survival outcomes of glioma bearing mice up to 40–60%. Importantly the oncolytic action of ZIKV extended beyond its anti-GSC effects. Reduction in tumor size and improved survival outcomes following oncolytic ZIKV treatment was caused by Perforin 1 activity in CD8+ T cells which clears tumor components not directly killed by ZIKV. In preliminary studies we observed that DC-2 and CCR2+ antigen presenting cell (APC) subsets are utilized by ZIKV to drive CD8+ T cells against GBM. This highlights the immunological barriers of GBM that can be overcome with ZIKV immunovirotherapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
CodeCraft的应助被忧郁的鱿鱼采纳,获得10
1秒前
molihuakai的应助被美满水绿采纳,获得10
1秒前
2秒前
乐乐的应助被ccyao采纳,获得10
4秒前
4秒前
科研通AI6.3的应助被三分之二采纳,获得50
4秒前
5秒前
pancake发布了新的文献求助50
5秒前
共享精神的应助被野菜采纳,获得10
5秒前
慕青的应助被拼搏可冥采纳,获得10
5秒前
Ava的应助被1900采纳,获得10
6秒前
6秒前
幸运鹅发布了新的文献求助10
7秒前
7秒前
cdercder的应助被追尾的猫采纳,获得20
8秒前
阿东发布了新的文献求助10
8秒前
柠浩发布了新的文献求助10
8秒前
LH完成签到,获得积分10
9秒前
10秒前
10秒前
大个的应助被彪壮的绮烟采纳,获得10
10秒前
涨誊完成签到,获得积分20
12秒前
AN发布了新的文献求助10
13秒前
阿申爱乐的应助被dalong采纳,获得40
13秒前
深情安青的应助被三分之二采纳,获得10
14秒前
yunlong完成签到 ,获得积分10
15秒前
15秒前
15秒前
西陆发布了新的文献求助10
16秒前
WilliamTT发布了新的文献求助10
16秒前
东方天奇完成签到 ,获得积分10
16秒前
17秒前
syvshc的应助被RuYi采纳,获得10
17秒前
18秒前
慕青的应助被阿耒采纳,获得10
18秒前
18秒前
SchoLar完成签到 ,获得积分10
18秒前
慕青的应助被脑子大聪明采纳,获得10
18秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177767
求助须知:如何正确求助?哪些是违规求助? 9568590
关于积分的说明 21799821
捐赠科研通 7772374
什么是DOI,文献DOI怎么找? 3432476
关于科研通互助平台的介绍 2556695
邀请新用户注册赠送积分活动 2478034